Alexandra Martin1, Winfried Rief, Antje Klaiberg, Elmar Braehler. 1. Philipps-University, Faculty of Psychology, Section of Clinical Psychology and Psychotherapy, Gutenbergstrasse 18, D-35032 Marburg, Germany. martin@staff.uni-marburg.de
Abstract
OBJECTIVE: The aim of this study was to assess the validity of the Patient Health Questionnaire depression module (PHQ-9). It has been subject to studies in medical settings, but its validity as a screening for depression in the general population is unknown. METHOD: A representative population sample (2,066 subjects, 14-93 years) filled in the PHQ-9 for diagnosis [major depressive disorder, other depressive disorder, depression screen-positive (DS+) and depression screen-negative (DS-)] and other measures for distress (GHQ-12), depression (Brief-BDI) and subjective health perception (EuroQOL; SF-36). RESULTS: A prevalence rate of 9.2% of a current PHQ depressive disorder (major depression 3.8%, subthreshold other depressive disorder 5.4%) was identified. The two depression groups had higher Brief-BDI and GHQ-12 scores, and reported lower health status (EuroQOL) and health-related quality of life (SF-36) than did the DS- group (P's < .001). Strong associations between PHQ-9 depression severity and convergent variables were found (with BDI r = .73, with GHQ-12 r = .59). CONCLUSION: The results support the construct validity of the PHQ depression scale, which seems to be a useful tool to recognize not only major depression but also subthreshold depressive disorder in the general population.
OBJECTIVE: The aim of this study was to assess the validity of the Patient Health Questionnaire depression module (PHQ-9). It has been subject to studies in medical settings, but its validity as a screening for depression in the general population is unknown. METHOD: A representative population sample (2,066 subjects, 14-93 years) filled in the PHQ-9 for diagnosis [major depressive disorder, other depressive disorder, depression screen-positive (DS+) and depression screen-negative (DS-)] and other measures for distress (GHQ-12), depression (Brief-BDI) and subjective health perception (EuroQOL; SF-36). RESULTS: A prevalence rate of 9.2% of a current PHQ depressive disorder (major depression 3.8%, subthreshold other depressive disorder 5.4%) was identified. The two depression groups had higher Brief-BDI and GHQ-12 scores, and reported lower health status (EuroQOL) and health-related quality of life (SF-36) than did the DS- group (P's < .001). Strong associations between PHQ-9 depression severity and convergent variables were found (with BDI r = .73, with GHQ-12 r = .59). CONCLUSION: The results support the construct validity of the PHQ depression scale, which seems to be a useful tool to recognize not only major depression but also subthreshold depressive disorder in the general population.
Authors: J Randall Curtis; Paul S Ciechanowski; Lois Downey; Julia Gold; Elizabeth L Nielsen; Sarah E Shannon; Patsy D Treece; Jessica P Young; Ruth A Engelberg Journal: Contemp Clin Trials Date: 2012-07-06 Impact factor: 2.226
Authors: Peter J Gianaros; Anna L Marsland; Lei K Sheu; Kirk I Erickson; Timothy D Verstynen Journal: Cereb Cortex Date: 2012-07-06 Impact factor: 5.357
Authors: Linda G Marc; Whitney R Henderson; Astrid Desrosiers; Marcia A Testa; Samuel E Jean; Eniko Edit Akom Journal: J Gen Intern Med Date: 2014-08-05 Impact factor: 5.128
Authors: Candice Taylor Lucas; Mary Jo Messito; Rachel S Gross; Suzy Tomopoulos; Arthur H Fierman; Carolyn Brockmeyer Cates; Samantha Berkule Johnson; Benard Dreyer; Alan L Mendelsohn Journal: J Nutr Educ Behav Date: 2016-10-15 Impact factor: 3.045
Authors: Sheila M McNallan; Alanna M Chamberlain; Yariv Gerber; Mandeep Singh; Robert L Kane; Susan A Weston; Shannon M Dunlay; Ruoxiang Jiang; Véronique L Roger Journal: Am Heart J Date: 2013-09-17 Impact factor: 4.749